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Background: Multidrug resistance remains a major obstacle to successful cancer chemotherapy. 
Some chemical multidrug resistance inhibitors, such as ciclosporin and verapamil, have been 
reported to reverse resistance in tumor cells. However, the accompanying side effects have limited 
their clinical application. In this study, we have developed a novel drug delivery system, ie, a 
polyethyleneglycol-polycaprolactone (PEG-PCL) copolymer micelle encapsulating doxorubicin, 
in order to circumvent drug resistance in adriamycin-resistant K562 tumor cells.
Methods: Doxorubicin-loaded diblock copolymer PEG-PCL micelles were developed, and the 
physicochemical properties of these micelles, and accumulation and cytotoxicity of doxorubicin 
in adriamycin-resistant K562 tumor cells were studied.
Results: Doxorubicin-loaded micelles were prepared using a solvent evaporation method with 
a diameter of 36 nm and a zeta potential of +13.8 mV . The entrapment efficiency of doxorubicin 
was 48.6% ± 2.3%. The micelles showed sustained release, increased uptake, and cellular cyto-
toxicity, as well as decreased efflux of doxorubicin in adriamycin-resistant K562 tumor cells.
Conclusion: This study suggests that PEG-PCL micelles have the potential to reverse multidrug 
resistance in tumor cells.
Keywords: doxorubicin, polyethylene glycol, polycaprolactone, adriamycin-resistant K562 
tumor cells, multidrug resistance, micelles
Introduction
Cancer is one of the leading causes of morbidity and accounts for a quarter of all deaths 
around the world. Chemotherapy is one of the most commonly used treatments for 
cancer, but chemotherapy resistance often limits its efficacy. One of the most frequent 
phenotypes of multidrug resistance is overexpression in tumor cells of P-glycoprotein, 
a 170 kDa multidrug resistance1 gene product.1–3 P-glycoprotein can actively pump 
out its substrates, resulting in reduced intracellular accumulation of certain drugs 
and decreased therapeutic efficacy. One approach to increasing drug accumulation in 
cells is to envelop the antitumor drug into nanoscale vehicles to escape recognition 
by P-glycoprotein.
Micelles formed by amphiphilic block copolymers have attracted significant attention in 
the medical field due to their various advantages for drug delivery,4 which include enhanced 
solubilization,5 stabilization, and delivery of challenging agents.6,7 Polymeric micelles 
are able to accommodate antitumor drugs in their hydrophobic core and thus exceed the 
solubility limit of hydrophobic drugs.8 Furthermore, the hydrophilic corona in micelles 
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provides a stabilizing interface between their inner core and 
the aqueous environment, which help drugs to stay in the cir-
culation over a certain length of time, and hence improve the 
therapeutic efficacy of the enveloped drugs.6,7,9   Furthermore, the 
nanosize of polymeric micelles can enhance drug accumulation 
in solid tumors by prolonging circulation of the drug in the 
blood, as well as having enhanced permeability and retention 
effects.10 In recent years, more and more studies have shown the 
potential of micelles to reverse multidrug resistance in tumors.11 
Several studies have been performed to envelop P-glycoprotein 
substrates in polymeric micelles or nanoparticles to circumvent 
drug resistance.12 Many amphiphilic agents have been found to 
be able to enhance cellular accumulation of anticancer drugs, 
resulting in sensitization of cells overexpressing P-glycoprotein. 
A good example of this is the Pluronic® family composed of 
polyethylene oxide-polypropylene oxide-polyethylene oxide 
triblock copolymers.13,14
Doxorubicin, an anthracycline antibiotic, plays an impor-
tant role in the treatment of leukemia. However, its effects 
are greatly impaired by multidrug resistance in leukemia 
cells.15 In the present study, we prepared a novel type of 
  doxorubicin-loaded micelle, and demonstrated that these 
micelles improved the cytotoxicity of doxorubicin by chang-
ing the intracellular kinetics of doxorubicin in adriamycin-
resistant K562 tumor cells.
Materials and methods
Materials
Doxorubicin hydrochloride was obtained from   Zhejiang Hisun 
Pharmaceutical Co Ltd (Taizhou, China). Monomethoxy-
capped polyethylene glycol (MPEG), and ξ-caprolactone 
was provided by Sigma Aldrich (St Louis, MO). The 
P-glycoprotein-overexpressing human leukemia cell line. 
Adriamycin-resistant K562 tumor cells and their P-glyco-
protein-nonexpressing counterparts, K562 cells, were gen-
erous gifts from the Second Affiliated Hospital of Zhejiang 
University School of Medicine, Hangzhou, China. RPMI-
1640 medium and fetal bovine serum were purchased from 
PAA Laboratories GmbH (Pasching, Austria). MTT was from 
Shanghai Sangon Biological Engineering Technology and 
Service Co Ltd (Shanghai, China). CH2Cl2, triethylamine, 
and other reagents were of analytical grade and supplied by 
Huadong Medical (Hangzhou, China).
Synthesis and characteristics of diblock 
copolymers of PEG-PCL
The PEG-PCL diblock copolymers were synthesized by 
an already reported method with minor modifications.16,17 
The chemical structure is shown in Figure 1A. Briefly, 
  ring-opening polymerization of ξ-caprolactone was induced 
by using MPEG as the macroinitiator and calcium ammoniate 
as the catalyst. The product was then purified by precipitat-
ing twice into cold methanol from CH2Cl2 solution, and was 
finally dried under vacuum at 40°C. The molecular weight 
of the segments in the diblock copolymer was determined by 
the intensity of the terminal proton signal of MPEG at 3.39 
ppm and the methylene proton signal of PCL at 2.31 ppm 
using  1H nuclear magnetic resonance spectroscopy. The 
weight ratio of the PEG-PCL repeated units calculated from 
the integral values of characteristic peaks was 3.19 (PCL 
4222-PEG 4225; EG/CL 3.19). Molecular weight obtained 
by gel permeation chromatography measurements was about 
17188 Da (Figure 1B).
Preparation of doxorubicin-loaded  
PEG-PCL micelles
Polymeric micelles containing doxorubicin hydrochloride 
were prepared by the solvent evaporation method.18,19 Briefly, 
doxorubicin hydrochloride 3 mg was dissolved in CH2Cl2 
2 mL in the presence of a triple molar ratio of triethylamine, 
and stirred at 500 rpm on a magnetic stirrer for 4 hours at 
room temperature. Then PEG-PCL copolymer 10 mg was 
added into the solvent and vortexed until it was totally 
  dissolved. Afterwards, the organic solution containing the 
drug and the polymer were added to 20 mL distilled water 
under vigorous ultrasonication. The mixture was first stirred 
vigorously at 1000 rpm for 1 hour and then slowly at 200 rpm 
overnight to allow slow evaporation of CH2Cl2 and forma-
tion of the micelles. The residual CH2Cl2 was completely 
removed by vacuum distillation using a rotary evaporator. 
The micelle solution, concentrated to 5 mL, was filtered with 
a syringe filter (pore size 0.22 µm) to eliminate the polymer 
and doxorubicin aggregates. All the procedures were carried 
out under light protection.
Characterization of micelles
The morphologies of the micelles were studied using transmis-
sion electron microscopy (Morgagni 268 D; FEI, Eindhoven, 
The Netherlands), and dynamic light   scattering (Malvern 
Nano ZS®, Malvern Instruments Ltd,   Worcestershire, UK) 
was used to determine the diameter. The zeta potential was 
measured using a Zetasizer Nano-Z (Malvern Instruments 
Ltd). Drug entrapment efficiency was calculated as the ratio 
between the amount of drug incorporated into the micelles 
and the total amount of drug. Free doxorubicin was separated 
by an ultrafiltration membrane (Millipore, Billerica, MA) 
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with a molecular weight cutoff of 50,000 Da, and doxo-
rubicin content was measured by high-performance liquid 
chromatography (Agilent 1100; Agilent Technologies, Inc, 
Santa Clara, CA).
In vitro release of doxorubicin  
from polymer micelles
Micelle solution 1 mL was transferred into dialysis bags 
(molecular weight cutoff 12,000 Da; Spectrum Laboratories, 
Rancho Dominguez, CA) and placed in 10 mL of phosphate-
buffered saline solution with addition of Tween-80 0.1%. 
A drug release study was performed at 37°C in a thermostatic 
shaker at a rate of 75 rpm. Three milliliters of the buffered 
solution outside the dialysis bag were removed for analysis 
at predetermined intervals, and replaced with fresh buffer 
solution. Doxorubicin concentration was determined using 
the high-performance liquid chromatography method, as 
described above.
Cytotoxicity assay
Cells were cultured in growth medium consisting of 
RPMI-1640 supplemented with 10% fetal bovine serum 
and 1% penicillin/streptomycin. Subculture was performed 
every other day. Adriamycin-resistant K562 tumor cells were 
maintained in a complete RPMI-1640 medium containing 
doxorubicin 1 µg/mL at 37°C in a humidified atmosphere 
of 5% CO2. The cells were cultured for 2 weeks in drug-free 
medium prior to their use. To examine the levels of resistance 
in the selected cell lines, the cells were seeded in 96-well 
plates at a density of 104 cells/well, and allowed to grow 
overnight. A specified concentration of doxorubicin-free 
or doxorubicin-loaded micelles was added into the culture 
medium on the following day. Control experiments were 
conducted in parallel by adding 20 µL of sterile water, and 
followed by 72 hours of cultivation at 37°C in a humidified 
5% CO2 atmosphere. Meanwhile, the cytotoxicity of the 
physical mixture of copolymer and doxorubicin solution 
was also determined. The cytotoxic activity of doxorubicin 
was evaluated using a standard MTT assay. All experi-
ments were performed in triplicate. Absorbance at 560 nm 
was determined using a microplate reader. The results were 
calculated using the following equation:
Cytotoxicity % =   (one experiment group/control 
group) × 100%
Determination of cellular uptake
In order to evaluate the accumulation of doxorubicin in 
adriamycin-resistant K562 tumor cells, a cell suspen-
sion containing different concentrations of doxorubicin 
solution or doxorubicin-loaded micelles, was seeded at a 
density of 2 × 106 cells/mL in 2 mL of growth medium. 
The plates were incubated for two hours. The culture 
medium was then removed. The cells were washed twice 
using ice-cold phosphate-buffered saline to remove non-
internalized doxorubicin, and subsequently resuspended 
in 1 mL of water. The cells were treated by probe-type 
ultrasonication to obtain the cell lysate. The lysate was 
centrifuged at 10,000 rpm for 5 minutes in a microcen-
trifuge (Eppendorf AG, Hamburg, Germany) to remove 
the cell debris. The supernatant was analyzed using 
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Figure 1 (A) Chemical structure and (B) molecular weight of diblock copolymer polyethylene glycol-polycaprolactone. Molecular weight was determined by gel permeation 
chromatography measurements.
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high-performance liquid chromatography (Waters 474) 
equipped with a 474   multiwavelength fluorescence detec-
tor (excitation 497 nm and emission 555 nm). Calibration 
curves of known concentrations of doxorubicin in water 
were used for quantification. The mobile phase used was 
acetonitrile/0.015 M NaH2PO4 solution (pH 4.5, 30:70), 
and the flow rate was kept at 1 mL/minute.
Confocal laser scanning microscopy
After adriamycin-resistant K562 tumor cells were seeded 
in 12-well plates at a density of 5 × 104 cells/well for 
24 hours, the cell culture medium was replaced by 1 mL of 
phosphate-buffered saline containing doxorubicin solution 
or doxorubicin-loaded micelle solution (doxorubicin con-
centration 24 µg/mL) for 30 minutes, 2 hours, and 2 hours. 
The cells were then examined by confocal laser scanning 
microscopy (Carl Zeiss, Shanghai Co Ltd, China) with an 
excitation wavelength of 458 nm.
Statistical analysis
All results were analyzed using Student’s t-test with a statisti-
cal significance level of P , 0.05.
Results
Properties of drug-loaded micelles
The shape and morphology of the micelles observed by 
transmission electron microscopy is shown in Figure 2 
(left). Presence of the micelles is shown by light spherical 
entities surrounded by dark staining. It can be seen that the 
diblock copolymers formed spherical particles with a small 
diameter and a narrow size distribution. Dynamic light 
scattering studies indicated that the mean diameter was 
around 36 nm (Figure 2, right) with a zeta potential of 
13.8 mV. The content of doxorubicin in the micelles was 
verified as 12.6%. Doxorubicin was encapsulated in the 
hydrophobic segment of the copolymer. The percentage 
entrapment efficiency depended largely on the drug/polymer 
ratio, and reached the highest value (48.15%) when the 
drug and copolymer weight ratio was 3:10 (Figure 3). This 
relatively low entrapment efficiency of micelles produced 
by the solvent evaporation method is probably due to slow 
leakage of doxorubicin into the dispersion medium during 
the stirring procedure.20
Envelopment of doxorubicin in micelles  
induced sustained release of doxorubicin 
in vitro
As shown in Figure 4, doxorubicin was released from 
micelles with an initial burst release, followed by a phase 
of slow release, and the percentage of release over 30 hours 
was around 70%. In comparison, doxorubicin solution was 
released completely within 2 hours. This indicates that 
envelopment of doxorubicin in the micelles resulted in 
  significantly sustained release of the drug, which is beneficial 
for drug action.
Envelopment of doxorubicin in micelles  
enhanced cytotoxicity and accumulation  
in adriamycin-resistant K562 tumor cells
Figure 5 shows the cytotoxicity of doxorubicin-loaded 
micelles and doxorubicin solution in K562 cells (left) and 
adriamycin-resistant K562 tumor cells (right). Viability was 
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Figure 2 Morphology and size distribution of doxorubicin-loaded polyethyleneglycol-polycaprolactone micelles. The morphologies of the micelles were studied using 
transmission electron microscopy (left). Dynamic light scattering was used to determine the diameter of micellar doxorubicin.
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Distribution of doxorubicin  
and drug-loaded micelles  
in multidrug-resistant K562 cells
The distribution of doxorubicin solution and doxorubicin-
loaded micelles in multidrug-resistant K562 cells was studied 
by confocal laser scanning microscopy. Figure 7 showed 
that after 30 minutes of cell incubation with free doxorubi-
cin, strong fluorescence was observed in the cells, whereas 
those cells exposed to free drug for two hours showed very 
weak fluorescence, and eight hours later, even less doxo-
rubicin was observed in the cells. In contrast with the cells 
treated using doxorubicin-free solution, cells incubated with 
  doxorubicin-loaded PEG-PCL micelles generated much 
weaker fluorescence at the time of 30 minutes, and a much 
stronger fluorescence after 8 hours of treatment. At 30   minutes, 
fluorescence in the cells was much weaker than that of the 
free doxorubicin. However, after 2 hours of incubation, doxo-
rubicin emitted strong fluorescence from the cells, and after 
8 hours, a lot of doxorubicin was still found in the cells.
Discussion
The smaller the nanoparticle size, the better its stability in 
aqueous solution.19 In the current study, we obtained micelles 
with a particle size smaller than the reported values.21,22 
This may be attributed to longer PEG chains and the lower 
molecular weight of the copolymer. The diameter of micelles 
depends largely on the hydrophilic/hydrophobic chain ratio, 
and higher PEG/PCL chain ratios produce smaller micelle 
diameters. Furthermore, a long PEG chain on the micelle 
surface could improve the stability of micelles because of a 
much lower critical micelle concentration.19 The polymer we 
synthesized has a much longer PEG chain compared with its 
PCL chain, which resulted in a much smaller particle size 
and improvement in micelle stability.
An in vitro release experiment indicated that envelopment 
of doxorubicin in micelles significantly delayed drug release, 
which could both enhance drug stability and prolong drug 
action. The initial burst which happened within the first few 
hours of incubation may be attributed to a relatively small 
amount of drug at the interface between the micelle hydro-
phobic core and hydrophilic corona.23,24 Several investiga-
tions have demonstrated that a sustained pattern of release 
of antitumor drug from the carrier would enhance tumor-
suppressive activity both in vitro24 and in vivo.25
Figure 5 shows that micellar doxorubicin had much 
greater cytotoxicity than doxorubicin solution in multidrug-
resistant K562 cells, indicating the potential of micellar 
doxorubicin to reverse multidrug resistance. The ability of 
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Figure 4 In vitro doxorubicin release profiles from doxorubicin-loaded micelles and 
doxorubicin solution. A drug release study was performed at 37°C under shaking 
(75 rpm) which was monitored using a dialysis bag containing phosphate-buffered 
saline with addition of 0.1% Tween-80 as a sink solution at pH 7.4.
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Figure 3 Entrapment efficiency of the doxorubicin in the micelle that was influenced by 
the quantity of added drug. The drug entrapment efficiency was the ratio (percentage) 
of the amount of drug incorporated into micelles to the total amount of the drug.
dramatically decreased in the K562 cells, and no significant 
differences were observed after incubating the cells with 
either doxorubicin solution or doxorubicin-loaded micelles 
for three days at doxorubicin concentrations of 3–12 µg/mL 
(P . 0.05). In the adriamycin-resistant K562 tumor cells, 
notably enhanced cytotoxicity was induced by drug-loaded 
micelles when compared with doxorubicin solution at a 
concentration of 6–12 µg/mL. At the same time, the physi-
cal mixture of polymer and doxorubicin showed the same 
cytotoxicity as the doxorubicin solution. Internalization of 
micellar doxorubicin and free doxorubicin in the adriamycin-
resistant K562 tumor cells was examined using fluorescent 
high-performance liquid chromatography. After two hours 
of incubation, envelopment of doxorubicin in the micelles 
significantly enhanced cellular accumulation of the drug, 
especially at an initial drug concentration of 6 µg/mL and 
12 µg/mL (Figure 6).
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micelles to enhance the cytotoxicity of the antitumor drug 
and reverse multidrug resistance has also been demonstrated 
by other reports. For example, Wang et al26 reported that 
micellar P105 and P105/L101 paclitaxel could overcome 
multidrug resistance in adriamycin-resistant MCF-7 tumor 
cells. The higher cytotoxic activity of doxorubicin-loaded 
micelles over free doxorubicin implies that doxorubicin 
encapsulated in PEG-PCL could elevate the intracellular 
concentration of doxorubicin through different transport 
process from doxorubicin solution, which was supported 
by the intracellular uptake study we performed. Yi et al27 
also reported that a doxorubicin-loaded amphiphilic copo-
lymer micelle composed of MPEG, poly 2-(dimethylamino)
ethyl methacrylate, and poly 2-(diethylamino)ethyl meth-
acrylate showed 38.1 times higher activity in adriamycin-
resistant MCF-7 tumor cells than free doxorubicin after 
three days of incubation. Furthermore, polyethylene 
  glycol-    block-polypropylene glycol-block-polyethylene 
glycol micelles loaded with doxorubicin could interact 
with multidrug resistance cancer cells, resulting in drastic 
sensitization of these tumor cells.13 However, the physical 
mixture of polymer and doxorubicin did not show enhanced 
cytotoxicity compared with the doxorubicin solution, indi-
cating that the cytotoxicity of the micelles was not induced 
or enhanced by polymer materials.
In the present study, we observed that doxorubicin 
entrapped in micelles could enhance drug accumulation in 
multidrug-resistant K562 cells, which is consistent with the 
finding that a series of diblock copolymers based on meth-
oxypolyethylene glycol-block-polycaprolactone enhanced 
cellular accumulation of another P-glycoprotein substrate, 
rhodamine-123, in Caco-2 cells.28,29 The increased accumula-
tion of doxorubicin in adriamycin-resistant K562 tumor cells 
indicated that doxorubicin-loaded micelles could enhance 
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Figure 5 Cytotoxicity determined by MTT assay in (A) K562 cells and (B) adriamycin-resistant K562 tumor cells. Cells were incubated with doxorubicin-loaded micelles, 
doxorubicin solution, and a physical mixture of the copolymer and doxorubicin for 72 hours. The doxorubicin concentration is varied. 
Notes: Error bars represent the standard deviations (n = 3): *P , 0.05; **P , 0.01. 
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Figure  6  The  intracellular  doxorubicin  amount  in  adriamycin-resistant  K562 
tumor cells. Doxorubicin uptake into the adriamycin-resistant K562 tumor cells 
after  incubation  with  different  drug  concentrations  of  micellar  doxorubicin  and 
doxorubicin solution for 2 hours.
Notes: *P , 0.05; **P , 0.01.
Figure 7 Distribution of doxorubicin in the multidrug-resistant K562 tumor cells. 
It  was  observed  under  confocal  microscopy  after  incubating  multidrug-resistant 
K562 tumor cells with free doxorubicin for (A) 0.5 hours, (B) 2 hours, (C) 8 hours, 
and doxorubicin-loaded copolymer polyethylene glycol-polycaprolactone micelles 
for (D) 30 minutes, (E) 2 hours, and (F) 8 hours.
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the sensitivity and uptake of adriamycin-resistant K562 
tumor cells by doxorubicin, which also hints at the potential 
of micellar doxorubicin to reverse P-glycoprotein-mediated 
multidrug resistance.
Confocal laser scanning microscopy results showed 
that after incubation of multidrug-resistant K562 cells with 
doxorubicin solution for half an hour, doxorubicin could 
enter the nucleus of these cells quickly, but less doxorubicin 
was found in the cells after two hours of incubation, and 
little doxorubicin was in the cells after eight hours. It has 
been suggested that free doxorubicin can also enter into 
drug-resistant cells at first, but is then pumped out of the 
cells quickly. As for the micellar doxorubicin, although it 
enters into the cells at a lower rate than free doxorubicin, 
it may not be pumped out until 2 or 8 hours. In addition, 
endocytosis may contribute a lot to the uptake of micellar 
doxorubicin by adriamycin-resistant K562 tumor cells, while 
the migration of free doxorubicin into the cells may mostly 
rely on a passive diffusion process. This may explain why 
free doxorubicin entered the cells more quickly than micellar 
doxorubicin. However, the micelles could be entrapped by 
endosomes and lysosomes, and thus would escape the efflux 
by P-glycoprotein.
Moreover, micelles released doxorubicin in a sustained 
way (Figure 4), and have enhanced cytotoxicity. Similar 
results were also obtained by Shuai et al16 and Savic et al.30 
Their studies showed that the patterns of cellular distribution 
of doxorubicin-loaded MPEG-PCL micelles and free doxo-
rubicin are different in PC12 cells. They demonstrated that 
micelles are internalized into PC12 cells via an endocytosis 
mechanism and doxorubicin in endosomes and lysosomes 
is higher for doxorubicin-loaded MPEG-PCL micelles, 
while free doxorubicin entered into the cells by diffusion. 
Allen et al31 also investigated cellular internalization of 
PCL-b-polyethylene oxide copolymer micelles in PC12 cells, 
and the internalization process of the micelles was found to 
fulfill the basic criteria of endocytosis (uptake was time-, 
temperature-, pH-, and energy-dependent).
Thus, based on the findings from our study and evidence 
from the literature, we propose that doxorubicin delivered by 
PEG-PCL copolymer micelle enters into cells via internaliza-
tion, and intracellular entry of doxorubicin-loaded micelles 
followed by entrapment in endosomes and lysosomes renders 
the drug inaccessible to P-glycoprotein. Micellar doxorubicin 
is released in a controlled manner from the micelle particles 
as shown in Figure 4, and eventually enters the nucleus 
where doxorubicin is known to exert its cytotoxicity during 
DNA synthesis.
In conclusion, biodegradable diblock copolymers of 
PEG-PCL was synthesized by ring-opening polymerization 
of ξ-caprolactone for effective delivery of doxorubicin, an 
anticancer drug, into tumor cells. This amphiphilic polymer 
self-assembled into core shell structural micelles, and encap-
sulated doxorubicin in the hydrophobic core. Compared with 
doxorubicin solution, micelle-delivered doxorubicin showed 
more potent cytotoxicity in   adriamycin-resistant K562 tumor 
cells, and enhanced accumulation of doxorubicin in tumor 
cells, indicating its ability to reverse multidrug resistance.
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